Nara Daubeney, Phaim
"It comes down to [the question], 'Why are you here?'. We looked at this project and thought, if we do this and it works, then we have a therapy that could prevent people from progressing down the inevitable slide into insulin dependence, with all the long term impacts that implies. And that would be a really worthwhile course to take." Nara Daubeney is the COO of Phaim, a Biotech company using antigenic immune modulation to treat diabetes and other conditions. Nara joined us to talk about her transition from a successful medical career into the world of start-up Biotech, taking the immune system back to school and why the "fire in your belly" should be your guide. Enjoy!